
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67269
Internal Medicine
Dermatology
A Rare Skin Lesion Presentation With Sarcoidosis
Muacevic Alexander
Adler John R
Hashem Sayed 1
Harby Rafat 1
Al-Sabah Humoud 2
Allafi Atlal 1
1 Dermatology, As'ad Al-Hamad Dermatology Center, Kuwait City, KWT
2 Dermatopathology, As'ad Al-Hamad Dermatology Center, Kuwait City, KWT
Sayed Hashem sayed_abba@hotmail.com
20 8 2024
8 2024
16 8 e6726920 8 2024
Copyright © 2024, Hashem et al.
2024
Hashem et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/270326-a-rare-skin-lesion-presentation-with-sarcoidosis
Sarcoidosis is a multifaceted systemic disease of uncertain aetiology, pathologically characterised by non-caseating granulomas. Typical symptoms include coughing, dyspnoea, chest pain and lesions affecting the eyes or skin. Cutaneous sarcoidosis frequently accompanies the involvement of other organs, but isolated cutaneous presentations are also observed. We present a case of cutaneous sarcoidosis in a 31-year-old Indian male. The diagnosis of sarcoidosis was confirmed by a skin biopsy, which showed that there is a naked, non-caseating granuloma filling the upper and deep dermis, formed of epithelioid histiocytes and multinucleated giant cells. Treatment with the intralesional steroid triamcinolone acetonide (5 mg/mL) monthly is considered. We hope to raise doctors' awareness of the various forms of sarcoidosis, consequently improving diagnostic skills and patient treatment.

uncommon skin lesion in sarcoidosis
rare presentation
unusual skin lesion
sarcoidosis
a rare skin lesion presentation with sarcoidosis
==== Body
pmcIntroduction

Sarcoidosis is an idiopathic illness that affects several body organs and is characterised by granulomatous inflammation [1]. Roughly 90% of cases involve the lungs, making them the most commonly implicated site [2].

However, cutaneous manifestations are also significant, occurring in 25% of patients with sarcoidosis and presenting as either specific or nonspecific lesions [3,4].

Similar to sarcoidosis in general, cutaneous sarcoidosis is more common in females [3,5]. It is unclear what causes sarcoidosis to develop in the first place. The theory suggests that the immunological response of T helper type 1 (Th1) to one or more extrinsic antigens is dysregulated. This dysregulation could result in the overactivation of inflammatory pathways and the consequent creation of granulomas [6].

Case presentation

For the case and related photos to be published, we have the consent of the patient.

A 31-year-old Indian male presented with a two-week history of well-defined, asymptomatic, flesh-coloured nodules with a rough, pebbly surface on the chin, located under the left lower vermilion border (Figure 1). The patient's neurological, respiratory and cardiovascular systems were normal upon additional examination, and no palpable lymphadenopathies or organomegaly was found in the locations that were accessible.

Figure 1 Nodule with a rough pebbly surface on the chin under the left lower vermilion border

Additionally, the serum angiotensin-converting enzyme (ACE) level was on the upper border (51.6 U/L).

The histopathological evaluation of the skin biopsy shows an attenuated epidermis. There is a naked, non-caseating granuloma filling the upper and deep dermis, formed of epithelioid histiocytes and multinucleated giant cells. There are a few lymphocytic infiltrations. No foreign body was seen (Figure 2).

Figure 2 Histopathology of the punch biopsy

The histopathological evaluation of the skin biopsy shows an attenuated epidermis. There is a naked, non-caseating granuloma filling the upper and deep dermis, formed of epithelioid histiocytes and multinucleated giant cells. There are few lymphocytic infiltrations. No foreign body was seen

Notably, the patient's chest X-ray film revealed bilateral hilar lymphadenopathy (BHL) (Figure 3).

Figure 3 Chest radiograph showing bilateral hilar lymphadenopathy

For localised cutaneous sarcoidosis, our recommended first-line treatment is intralesional or topical corticosteroid therapy [7].

The treatment plan included receiving intralesional steroid triamcinolone acetonide (5 mg/mL) monthly, as he received two injections in addition to topical steroids and was advised to continue the treatment.

His skin lesions were significantly improved after three months, and the patient was happy with the outcome (Figure 4).

Figure 4 Follow-up after three months

After three months, his skin lesions had greatly improved, and the patient was pleased with the result

Discussion

Sarcoidosis is a multisystem disorder primarily caused by environmental triggers and genetic factors. Pulmonary involvement occurs in approximately 90% of cases, and common cutaneous manifestations include plaques and papules, which are most frequently observed on the trunk, face and upper extremities [3,5].

Sarcoidosis's aetiology is still unknown, yet theories point to a chronic immune response in genetically predisposed people exposed to unknown exogenous antigens [7]. Granuloma formation in sarcoidosis is a hallmark of the disease, involving a complex immune response. It begins with antigen exposure, activates immune cells such as macrophages and dendritic cells and releases cytokines such as interferon gamma (IFN-γ) and tumour necrosis factor-alpha (TNF-α). These cells recruit and activate more macrophages, forming the core of the granuloma, surrounded by lymphocytes and fibroblasts [8]. Clinically, sarcoidosis can present with a wide range of cutaneous symptoms. It can be difficult to diagnose because of its similarities to other conditions, such as erythema nodosum, lupus pernio and maculopapular or plaque-like eruptions; however, research remains in progress in order to clarify this condition [7].

Serum angiotensin-converting enzyme (ACE) levels are elevated in 75% of untreated sarcoidosis patients, but their diagnostic utility is limited due to poor sensitivity and insufficient specificity, with false-positive rates. For an accurate diagnosis, a biopsy of the skin lesion is recommended, and a clinical suspicion should be formed [9].

Topical corticosteroids or intralesional steroids are usually used as standard treatment for cutaneous sarcoidosis. However, systemic steroids may be used with methotrexate or an antimalarial medication if these treatments are ineffective [10]. In our case, we administered the intralesional steroid triamcinolone acetonide (5 mg/mL) monthly.

Conclusions

This case is notable for the isolated cutaneous presentation of sarcoidosis in a young male patient, which is less expected given the disease's preference for females. It underscores the importance of considering sarcoidosis in the differential diagnosis of atypical skin lesions, even without systemic involvement. In this case, the successful use of intralesional steroids highlights the potential for localised therapy to achieve positive outcomes in similar presentations.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Sayed Hashem, Rafat Harby, Humoud Al-Sabah, Atlal Allafi

Acquisition, analysis, or interpretation of data:  Sayed Hashem, Rafat Harby, Humoud Al-Sabah, Atlal Allafi

Drafting of the manuscript:  Sayed Hashem, Rafat Harby, Humoud Al-Sabah, Atlal Allafi

Critical review of the manuscript for important intellectual content:  Sayed Hashem, Rafat Harby, Humoud Al-Sabah, Atlal Allafi

Supervision:  Atlal Allafi
==== Refs
References

1 Sarcoidosis N Engl J Med Iannuzzi MC Rybicki BA Teirstein AS 2153 2165 357 2007 18032765
2 Hepatic sarcoidosis J Clin Transl Hepatol Tadros M Forouhar F Wu GY 87 93 1 2013 26357609
3 Prevalence and characteristics of cutaneous sarcoidosis in Argentina Int J Womens Dermatol Abed Dickson M Hernández BA Marciano S Mazzuoccolo LD 280 284 7 2021 34222584
4 Cutaneous involvement in sarcoidosis. Relationship to systemic disease Arch Dermatol Mañá J Marcoval J Graells J Salazar A Peyrí J Pujol R 882 888 133 1997 9236527
5 Sarcoidosis and its dermatological manifestations: a narrative review Cureus Koneti J Cherukuri SP Gadde S Kalluru R Chikatimalla R Dasaradhan T 0 14 2022
6 Cutaneous sarcoidosis Postgrad Med J Wilson NJ King CM 649 652 74 1998 10197194
7 Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease J Am Acad Dermatol Haimovic A Sanchez M Judson MA Prystowsky S 699 618 66 2012
8 Pathogenesis of sarcoidosis West J Med Van Gundy K Sharma OP 168 174 147 1987 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1025770/ 3310401
9 Cutaneous sarcoidosis: a retrospective clinico-pathological study from the Indian subcontinent in patients attending a tertiary health care centre Indian Dermatol Online J Mahabal GD Peter DC George L Thomas M Pulimood SA 566 571 12 2021 34430461
10 Evidence-based therapy for cutaneous sarcoidosis Drugs Doherty CB Rosen T 1361 1383 68 2008 18578557
